APA (7th ed.) Citation

Wang, R., Guo, T., Wang, Q., Gao, W., Yu, Y., Zhang, J., . . . Zhang, B. (2025). The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-13457-w

Chicago Style (17th ed.) Citation

Wang, Ruifeng, Tianhui Guo, Qi Wang, Wen Gao, Yimiao Yu, Jun Zhang, Wenqian Fu, Haiji Wang, and Biyuan Zhang. "The Efficacy and Safety of Induction Chemotherapy Combined with Sintilimab Followed by Concurrent Chemoradiotherapy Plus Sintilimab Sequencing Maintaining with Sintilimab for Patients with Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-13457-w.

MLA (9th ed.) Citation

Wang, Ruifeng, et al. "The Efficacy and Safety of Induction Chemotherapy Combined with Sintilimab Followed by Concurrent Chemoradiotherapy Plus Sintilimab Sequencing Maintaining with Sintilimab for Patients with Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-13457-w.